Saturday 17 October 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024. In the quarter to June 2026, revenue grew 65.7%, EPS grew 66.7% and free cash flow grew 11.5%, each against the same quarter a year earlier.

13.58 1.14 −7.74%

Follow IOVA

Alert me

Market cap: $6.7B
P/E: 0.0×
Fwd P/E: −7.8×
Dividend yield: —
F-score: 4/9
Altman Z: −2.30
Beneish M: −2.46
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	6	4	—	—	+8 more TTM periods Free account
ROE Full definition →	(40.36%)	(47.51%)	(55.50%)	(53.89%)
ROA Full definition →	(31.76%)	(37.40%)	(42.88%)	(41.94%)
ROIC Full definition →	(42.96%)	(55.59%)	(62.77%)	(64.83%)
Return on Tangible Assets Full definition →	(59.22%)	(75.53%)	(89.79%)	(92.48%)
Average Days of Receivables Full definition →	114.70	104.48	114.21	97.31
Free Cash Flow per Share Full definition →	(0.66)	(0.73)	(0.94)	(0.97)
Free Cash Flow Full definition →	(296.39)	(305.02)	(336.24)	(351.82)
Capital Expenditures Full definition →	(32.21)	(34.23)	(33.84)	(28.68)
Other line items
Cash ROIC Full definition →	(28.67%)	(29.47%)	(33.77%)	(35.07%)
Accounts Receivable Turnover Full definition →	4.01	3.74	3.47	4.09
Accounts Payable Turnover Full definition →	5.76	5.25	6.97	4.87
Inventory Turnover Full definition →	3.18	2.79	3.36	3.39
Average Days of Payables Full definition →	57.05	79.03	46.70	74.44
Days of Inventory on Hand Full definition →	121.01	123.19	108.92	123.22
Tax Rate Full definition →	(0.01)	0.00	(0.01)	0.00
Research and Development Expense of Revenue Full definition →	82.38%	100.41%	113.95%	118.36%
Selling, General and Administrative Expense of Revenue Full definition →	45.90%	51.63%	57.81%	63.05%
Share Based Compensation of Revenue Full definition →	14.38%	17.48%	23.37%	32.24%
Operating CF/Net income Full definition →	0.91	0.77	0.77	0.81
Depreciation/Fixed assets Full definition →	0.30	0.30	0.31	0.34
Capex/Depreciation Full definition →	(0.82)	(0.86)	(0.84)	(0.66)
Revenue per Share Full definition →	0.72	0.68	0.74	0.69
Operating CF per Share Full definition →	(0.59)	(0.65)	(0.85)	(0.89)
Capex per Share Full definition →	(0.07)	(0.08)	(0.09)	(0.08)
Capex to Sales Full definition →	0.10	0.12	0.13	0.11

Show all line items

Columns are period end dates

Stockrow Weekly